The trend toward larger deal sizes is likely to continue as companies seek to bolster their pipelines amid a looming patent ...

Plus: A stomach flu vaccine, the health impacts of California’s wildfires, lots of nine-figure deals for healthcare startups ...

San Francisco and its hotel industry are partnering to beef up security around this week's 43rd annual J.P. Morgan Healthcare ...

The conference runs from Monday through Thursday after two years of unprecedented underperformance for the healthcare sector.

Global Phase 3 HCV Program Expected to Initiate in 1Q 2025 Potential Best-in-Class Profile of Bemnifosbuvir + Ruzasvir ...

Industry leaders from more than 500 companies scheduled to give investor presentations will see heightened security ...

Potential antitrust deregulation could foster a more favourable environment for larger M&A deals in 2025, though skepticism ...

The four-day conference drew roughly 8,000 attendees and featured presentations from more than 500 private and public ...

Security is top of mind at the JP Morgan Healthcare conference underway in San Francisco ...

Trump administrations pro-corporation policies boost healthcare M&A prospects Healthcare investment outlook improves as Trump ...

Welcome to the Novartis presentation at the 43rd JPMorgan Healthcare Conference. I'm Richard Vosser, European pharma analyst with JPMorgan. It's my great pleasure to introduce Vas Narasimhan, the CEO ...